Jan-Willem van Ginkel

Program & Project Manager supporting companies to settle and grow at the Utrecht Science Park. Supporting early-stage biotech companies to move from R&D to GMP through targeted advice, and CDMO and Project Management.

Utrecht, Utrecht, Netherlands

About

Using over 15 years of experience within the life sciences biotech industry, I support companies who would like to settle and grow at the ๐—จ๐˜๐—ฟ๐—ฒ๐—ฐ๐—ต๐˜ ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฃ๐—ฎ๐—ฟ๐—ธ. With the in-depth knowledge of the requirements and regulations in the field, I can easily translate the needs and questions these companies have into solid advice and support, ensuring they will find a sustainable place to settle and grow at the park or its satellite locations in Bilthoven or Zeist. Additionally, through ๐—š๐—ถ๐—ป๐—–๐—ผ ๐—•๐—ถ๐—ผ๐˜๐—ฒ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€, I can provide operational support and advice to biotech start-ups and academic centers at the park and beyond to enable their transition from R&D to GMP via targeted advice, CDMO- and Project Management. ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป๐—ฎ๐—น ๐—ฃ๐—ฟ๐—ผ๐—ณ๐—ถ๐—น๐—ฒ: โ–ช Strategic and versatile biotech professional with 15+ years of experience in Program & Project Management, Cell & Gene Therapy, and clinical manufacturing. โ–ช Strong networking capabilities, able to connect and align stakeholders from different organizations. โ–ช Recognized for translating strategic vision into executable plans, accelerating development timelines, and ensuring regulatory and GMP compliance in dynamic, fast-growing organizations. ๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ฒ๐—ป๐—ฐ๐—ถ๐—ฒ๐˜€: โ–ช Project & Program Management โ–ช Strategic thinking โ–ช Leadership and team management โ–ช Adaptability and change management โ–ช Establish oversight and structure โ–ช Collaboration and stakeholder communication โ–ช Knowledge of GMP and ATMP guidelines and regulations โ–ช Excel in fast-paced, dynamic environments

Experience

  • Program & Project Manager Companies at Utrecht Science Park
    May 2026 - Present ยท 2 mos

    I support companies to settle and grow at the Utrecht Science Park, or its satellite locations in Bilthoven and Zeist. Why settle at the Utrecht Science Park? ๐Ÿ”นIt is the largest science park of The Netherlands ๐Ÿ”นIt is the home of over 170 organizations and institutions ๐Ÿ”นIt forms a unique concentration of knowledge and vibrant ecosystem Through collaboration we establish break-through solutions within life sciences, health and sustainability. Hence, we welcome companies with the ambition to play a key role in this. If you are an R&D company and would like to know more about the possibilities the Utrecht Science Park has to offer, reach out to me and weโ€™ll explore opportunities.

  • Biotech Consultant at Resilient Collective
    Dec 2025 - Present ยท 7 mos

    ๐Ÿ”นI joined Resilient Collective (RC) as a Biotech Consultant (ATMPs, CMC, Project & Alliance Management) ๐Ÿ”นRC connects companies with a trusted network of independent consultants offering expertise across scientific, technical, and business functions with no cost to the client. ๐Ÿ”นThe heart of Resilient Collective is our dynamic platform designed to connect companies with the right independent consultants. ๐Ÿ”นWhether youโ€™re navigating early R&D, scaling operations, or tackling complex challenges, our platform makes it easy to find the expertise you need. ๐Ÿ”นResilient Collective is your gateway to unlocking the full potential of your biotech company ๐Ÿ”นWhen you work with one of the RC consultants, youโ€™re gaining a trusted partner dedicated to helping your company thrive.

  • Founder GinCo Biotech Solutions at GinCo Biotech Solutions
    Nov 2025 - Present ยท 8 mos

    ๐—š๐—ถ๐—ป๐—–๐—ผ ๐—•๐—ถ๐—ผ๐˜๐—ฒ๐—ฐ๐—ต ๐—ฆ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€ supports biotech organizations in bringing their advanced therapies from concept to clinic, efficiently and compliant. With over 15 years of international experience in Biotech industry, ATMP development, GMP compliance, and leadership, GinCo turns complex strategies into executable programs that accelerate access to patients. ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ผ๐—ป Help organizations bring innovative therapies to patients faster and more efficiently, keeping quality and compliance in mind. ๐—ฉ๐—ถ๐˜€๐—ถ๐—ผ๐—ป The ATMP biotech landscape is evolving rapidly. New technologies, changing regulations, and shifting manufacturing perspectives create both opportunities and challenges. GinCo strives to be the trusted partner that connects strategy with execution, enabling teams to focus on what matters most: advancing therapies that improve lives. ๐—ฆ๐—ฒ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ The different biotech sectors GinCo aims to work with face different challenges: Academic centers: translating scientific innovation into compliant clinical products Start-ups: manage partnerships and meet regulatory milestones Scale-ups: define strategy and manage complexity Biopharma: provide interim leadership and strengthen programs ๐—ฆ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ GinCo provides the following services to provide tailored solutions to these different organizations: Alliance Management: build sustainable partnerships (CMO/CRO contracting & Tech Transfers) Project & Program Management: turn strategy into action Interim Leadership: ensure stability and progress Governance: provide structure that drives progress

  • Head of Global Site Management (Director) at Galapagos
    Dec 2023 - Sep 2025 ยท 1 yr 10 mos

    ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐˜€๐—ถ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€: > Drive strategic expansion of decentralized manufacturing network across EU, US, and APAC. > Lead due diligence and contract negotiations with external manufacturing partners. > Collaborate with Clinical Ops & Executive Leadership to align strategy with execution. > Manage Global Site Management Team. ๐—ž๐—ฒ๐˜† ๐—ฟ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€: Built supply & demand processes and operational tools enabling Phase II readiness and long-term global scalability.

  • Associate Director, Site Management at CellPoint
    Jul 2021 - Nov 2023 ยท 2 yrs 5 mos

    ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ผ๐—ป๐˜€๐—ถ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€: Directed technology transfers to EU & US sites; designed and implemented site management processes and tools. Built and led EU Site Management team (from 1 to 8 team members) and established US team including hiring US lead. ๐—ž๐—ฒ๐˜† ๐—ฅ๐—ฒ๐˜€๐˜‚๐—น๐˜๐˜€: Delivered IMPD submission and first patient treatment in EU (2022) and IND submission & approval in US (2024) by establishing reliable external manufacturing partnerships.